{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T14:25:53Z","timestamp":1790259953891,"version":"4.1.0"},"reference-count":105,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T00:00:00Z","timestamp":1704326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Unlike classic APS, CAPS causes multiple microthrombosis due to an increased inflammatory response, known as a \u201cthrombotic storm\u201d. CAPS typically develops after infection, trauma, or surgery and begins with the following symptoms: fever, thrombocytopenia, muscle weakness, visual and cognitive disturbances, abdominal pain, renal failure, and disseminated intravascular coagulation. Although the presence of antiphospholipid antibodies in the blood is one of the diagnostic criteria, the level of these antibodies can fluctuate significantly, which complicates the diagnostic process and can lead to erroneous interpretation of rapidly developing symptoms. Triple therapy is often used to treat CAPS, which includes the use of anticoagulants, plasmapheresis, and high doses of glucocorticosteroids and, in some cases, additional intravenous immunoglobulins. The use of LMWH is recommended as the drug of choice due to its anti-inflammatory and anticoagulant properties. CAPS is a multifactorial disease that requires not only an interdisciplinary approach but also highly qualified medical care, adequate and timely diagnosis, and appropriate prevention in the context of relapse or occurrence of the disease. Improved new clinical protocols and education of medical personnel regarding CAPS can significantly improve the therapeutic approach and reduce mortality rates.<\/jats:p>","DOI":"10.3390\/ijms25010668","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T05:23:30Z","timestamp":1704345810000},"page":"668","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Catastrophic Antiphospholipid Syndrome"],"prefix":"10.3390","volume":"25","author":[{"given":"Victoria","family":"Bitsadze","sequence":"first","affiliation":[{"name":"Department of Obstetrics, Gynecology and Perinatal Medicine, N. F. Filatov Clinical Institute of Children\u2019s Health, I. M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str. 8-2, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fidan","family":"Yakubova","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Perinatal Medicine, N. F. Filatov Clinical Institute of Children\u2019s Health, I. M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str. 8-2, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0725-9686","authenticated-orcid":false,"given":"Jamilya","family":"Khizroeva","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Perinatal Medicine, N. F. Filatov Clinical Institute of Children\u2019s Health, I. M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str. 8-2, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2136-1641","authenticated-orcid":false,"given":"Arina","family":"Lazarchuk","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Perinatal Medicine, N. F. Filatov Clinical Institute of Children\u2019s Health, I. M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str. 8-2, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2011-1237","authenticated-orcid":false,"given":"Polina","family":"Salnikova","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Perinatal Medicine, N. F. Filatov Clinical Institute of Children\u2019s Health, I. M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str. 8-2, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Vorobev","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Perinatal Medicine, N. F. Filatov Clinical Institute of Children\u2019s Health, I. M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str. 8-2, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Tretyakova","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Perinatal Medicine, N. F. Filatov Clinical Institute of Children\u2019s Health, I. M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str. 8-2, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8100-0189","authenticated-orcid":false,"given":"Natalia","family":"Degtyareva","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Perinatal Medicine, N. F. Filatov Clinical Institute of Children\u2019s Health, I. M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str. 8-2, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Grigoreva","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Perinatal Medicine, N. F. Filatov Clinical Institute of Children\u2019s Health, I. M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str. 8-2, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0764-4477","authenticated-orcid":false,"given":"Nilufar","family":"Gashimova","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Perinatal Medicine, N. F. Filatov Clinical Institute of Children\u2019s Health, I. M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str. 8-2, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Kvaratskheliia","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Perinatal Medicine, N. F. Filatov Clinical Institute of Children\u2019s Health, I. M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str. 8-2, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nataliya","family":"Makatsariya","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Perinatal Medicine, N. F. Filatov Clinical Institute of Children\u2019s Health, I. M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str. 8-2, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Kudryavtseva","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Perinatal Medicine, N. F. Filatov Clinical Institute of Children\u2019s Health, I. M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str. 8-2, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Tomlenova","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Perinatal Medicine, N. F. Filatov Clinical Institute of Children\u2019s Health, I. M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str. 8-2, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9899-9910","authenticated-orcid":false,"given":"Jean-Christophe","family":"Gris","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Perinatal Medicine, N. F. Filatov Clinical Institute of Children\u2019s Health, I. M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str. 8-2, 119991 Moscow, Russia"},{"name":"Faculty of Pharmaceutical and Biological Sciences, Montpellier University, 34093 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Elalamy","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Perinatal Medicine, N. F. Filatov Clinical Institute of Children\u2019s Health, I. M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str. 8-2, 119991 Moscow, Russia"},{"name":"Department Hematology and Thrombosis Center, Medicine Sorbonne University, 75012 Paris, France"},{"name":"Hospital Tenon, 4 Rue de la Chine, 75020 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2607-9717","authenticated-orcid":false,"given":"Cihan","family":"Ay","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Perinatal Medicine, N. F. Filatov Clinical Institute of Children\u2019s Health, I. M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str. 8-2, 119991 Moscow, Russia"},{"name":"Department of Medicine I, Clinical Division of Hematology and Hemostaseology, Medical University of Vienna, 1080 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Makatsariya","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology and Perinatal Medicine, N. F. Filatov Clinical Institute of Children\u2019s Health, I. M. Sechenov First Moscow State Medical University (Sechenov University), Trubetskaya Str. 8-2, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,1,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/art.42624","article-title":"The 2023 ACR\/EULAR Antiphospholipid Syndrome Classification Criteria","volume":"75","author":"Barbhaiya","year":"2023","journal-title":"Arthritis Rheumatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/0885066606287041","article-title":"Catastrophic antiphospholipid syndrome","volume":"21","author":"Vora","year":"2006","journal-title":"J. Intensive Care Med."},{"key":"ref_3","first-page":"39","article-title":"Antiphospholipid anti-bodies, their pathogenetic and diagnostic issues obstetric practice","volume":"8","author":"Bitsadze","year":"2014","journal-title":"Obstet. Gynecol. Reprod."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1191\/0961203303lu394oa","article-title":"Catastrophic antiphospholipid syndrome: International consensus statement on classification criteria and treatment guidelines","volume":"12","author":"Asherson","year":"2003","journal-title":"Lupus"},{"key":"ref_5","first-page":"508","article-title":"The catastrophic antiphospholipid syndrome","volume":"19","author":"Asherson","year":"1992","journal-title":"J. Rheumatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1177\/0961203312436866","article-title":"CAPS Registry","volume":"21","author":"Cervera","year":"2012","journal-title":"Lupus"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1055\/s-0032-1304718","article-title":"Update on the catastrophic antiphospholipid syndrome and the \u2018CAPS Registry\u2019","volume":"38","author":"Cervera","year":"2012","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1177\/0961203320951260","article-title":"16th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome","volume":"29","author":"Cervera","year":"2020","journal-title":"Lupus"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.autrev.2006.06.011","article-title":"Catastrophic antiphospholipid (Asherson\u2019s) syndrome and genetic thrombophilic disorders in obstetrics","volume":"6","author":"Makatsariya","year":"2006","journal-title":"Autoimmun. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/rheumatology\/keaa203","article-title":"EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies","volume":"60","author":"Pregnolato","year":"2021","journal-title":"Rheumatology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMra1112830","article-title":"The pathogenesis of the antiphospholipid syndrome","volume":"368","author":"Giannakopoulos","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrrheum.2011.52","article-title":"Pathogenesis of antiphospholipid syndrome: Understanding the antibodies","volume":"7","author":"Meroni","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1182\/blood-2009-12-260976","article-title":"Beta2-Glycoprotein I can exist in 2 conformations: Implications for our understanding of the antiphospholipid syndrome","volume":"116","author":"Sprenger","year":"2010","journal-title":"Blood"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.1538-7836.2011.04327.x","article-title":"\u03b2(2)-Glycoprotein I: Evolution, structure and function","volume":"9","author":"Meijers","year":"2011","journal-title":"J. Thromb. Haemost."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1182\/blood-2011-01-333617","article-title":"In vivo distribution of \u03b22 glycoprotein I under various pathophysiologic conditions","volume":"118","author":"Agostinis","year":"2011","journal-title":"Blood"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1095\/biolreprod.110.083410","article-title":"Antiphospholipid antibodies affect human endometrial angiogenesis","volume":"83","author":"Castellani","year":"2010","journal-title":"Biol. Reprod."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"805","DOI":"10.18632\/oncotarget.26612","article-title":"Antiphospholipid immune complexes as thrombosis risk marker","volume":"10","author":"Serrano","year":"2019","journal-title":"Oncotarget"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1182\/blood-2017-11-814681","article-title":"Thrombosis and Hemostasis: Antiphospholipid antibodies induce thrombosis by PP2A activation via apoER2-Dab2-SHC1 complex formation in endothelium","volume":"131","author":"Sacharidou","year":"2018","journal-title":"Blood"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1182\/blood-2010-07-299099","article-title":"Apolipoprotein E receptor 2 is involved in the thrombotic com-plications in a murine model of the antiphospholipid syndrome","volume":"117","author":"Urbanus","year":"2011","journal-title":"Blood"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/0961203309360841","article-title":"Antiphospholipid antibodies and the protein C pathway","volume":"19","author":"Urbanus","year":"2010","journal-title":"Lupus"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1136\/ard.2005.045237","article-title":"Annexin A5 polymorphism (-1C->T) and the presence of anti-annexin A5 antibodies in the antiphospholipid syndrome","volume":"65","author":"Derksen","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/0961203310361485","article-title":"The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: Role in pregnancy losses and thrombosis","volume":"19","author":"Rand","year":"2010","journal-title":"Lupus"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1177\/0961203308091633","article-title":"Prothrombotic mechanisms based on the impairment of fibrinolysis in the antiphospholipid syndrome","volume":"17","author":"Forastiero","year":"2008","journal-title":"Lupus"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1182\/blood.2020010575","article-title":"Markers of complement activation in plasma during quiescent phases in patients with catastrophic antiphospholipid syndrome","volume":"137","author":"Ruffatti","year":"2021","journal-title":"Blood"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.autrev.2019.03.015","article-title":"Evidence of complement activation in the thrombotic small vessels of a patient with catastrophic antiphospholipid syndrome treated with eculizumab","volume":"18","author":"Ruffatti","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1182\/blood.2019003863","article-title":"Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS","volume":"135","author":"Chaturvedi","year":"2020","journal-title":"Blood"},{"key":"ref_28","first-page":"12","article-title":"The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome\u2014Molecular mimicry?","volume":"27","author":"Asherson","year":"2000","journal-title":"J. Rheumatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/ard.2005.045443","article-title":"Infectious origin of the antiphospholipid syndrome","volume":"65","author":"Shoenfeld","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4103\/0972-5229.117077","article-title":"All that seems sepsis is not sepsis","volume":"17","author":"Guleria","year":"2013","journal-title":"Indian J. Crit. Care Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/humrep\/der402","article-title":"Investigation of systemic inflammatory response in first trimester pregnancy failure","volume":"27","author":"Jauniaux","year":"2012","journal-title":"Hum. Reprod."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ajh.10268","article-title":"Catastrophic antiphospholipid antibody Syndrome","volume":"72","author":"Moll","year":"2003","journal-title":"Am. J. Hematol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1177\/0961203313491024","article-title":"Catastrophic antiphospholipid syndrome with concurrent thrombotic and hemorrhagic manifestations","volume":"22","author":"Rangel","year":"2013","journal-title":"Lupus"},{"key":"ref_34","first-page":"1983","article-title":"Antiphospholipid syndrome (APS) nephropathy in catastrophic, primary, and systemic lupus erythematosus-related APS","volume":"35","author":"Tektonidou","year":"2008","journal-title":"J. Rheumatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.autrev.2016.09.010","article-title":"Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry","volume":"15","author":"Moitinho","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jamadermatol.2022.5221","article-title":"Cutaneous Involvement in Catastrophic Antiphospholipid Syndrome in a Multicenter Cohort of 65 Patients","volume":"159","author":"Morel","year":"2023","journal-title":"JAMA Dermatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1080\/09273948.2020.1830122","article-title":"Catastrophic Antiphospholipid Syndrome: Skin, Eye and Brain Involvement","volume":"30","author":"Sanchez","year":"2022","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"110","DOI":"10.5812\/nephropathol.9215","article-title":"Catastrophic antiphospholipid syndrome presented with sudden renal failure and history of long-lasting psychosis and hypertension in a 42 years old women","volume":"2","author":"Mardani","year":"2013","journal-title":"J. Nephropathol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.amjms.2022.08.010","article-title":"Bilateral adrenal hemorrhage: A rare presentation of catastrophic an-ti-phospholipid syndrome","volume":"365","author":"Oredegbe","year":"2023","journal-title":"Am. J. Med. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1097\/IAE.0000000000003185","article-title":"Catastrophic antiphospholipid syndrome and posterior ocular involvement: Case Series of 11 Patients and Literature Review","volume":"41","author":"Morel","year":"2021","journal-title":"Retina"},{"key":"ref_41","first-page":"11","article-title":"Catastrophic Anti-Phospholipid Syndrome in Systemic Lupus Erythematosus: A Tsunami in the Ocean","volume":"70","author":"Dorji","year":"2022","journal-title":"J. Assoc. Physicians India"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00431-011-1548-9","article-title":"Catastrophic antiphospholipid syndrome: First signs in the neonatal period","volume":"170","author":"Cabral","year":"2011","journal-title":"Eur. J. Pediatr."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e1523","DOI":"10.1542\/peds.2009-2939","article-title":"Infant with probable catastrophic antiphospholipid syndrome successfully managed with rituximab","volume":"125","author":"Neth","year":"2010","journal-title":"Pediatrics"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/0961203320965692","article-title":"Pediatric catastrophic antiphospholipid syndrome patient evolving to systemic lupus erythematosus","volume":"30","author":"Silva","year":"2021","journal-title":"Lupus"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1177\/09612033221118819","article-title":"Catastrophic antiphospholipid syndrome with Epstein-Barr virus-associated he-mophagocytosis: A clinicopathological conference","volume":"31","author":"Nawata","year":"2022","journal-title":"Lupus"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1177\/09612033221093496","article-title":"Small intestine necrosis in catastrophic antiphospholipid syndrome: A rare and severe case","volume":"31","author":"Christiansen","year":"2022","journal-title":"Lupus"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/ajh.26138","article-title":"A rare case of catastrophic antiphospholipid syndrome triggered by estrogen-containing oral contraceptives in a patient with double heterozygous factor V Leiden and prothrombin G20210A mutations","volume":"97","author":"McRae","year":"2022","journal-title":"Am. J. Hematol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s13224-017-0974-7","article-title":"Rare Presentation of Catastrophic Antiphospholipid Syndrome with Myocarditis in Post-partum Period: Case Report and Review of Literature","volume":"68","author":"Girish","year":"2018","journal-title":"J. Obstet. Gynecol. India"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejogrb.2021.07.002","article-title":"Catastrophic antiphospholipid syndrome during pregnancy","volume":"264","author":"Carrasco","year":"2021","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.3109\/14767058.2016.1160047","article-title":"Catastrophic antiphospholipid syndrome in pregnancy, a diagnosis that should not be missed","volume":"29","author":"Hoayek","year":"2016","journal-title":"J. Matern. Neonatal Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1741-7015-11-92","article-title":"Coagulopathy triggered autoimmunity: Experimental antiphospholipid syndrome in factor V Leiden mice","volume":"11","author":"Katzav","year":"2013","journal-title":"BMC Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"32","DOI":"10.17749\/2070-4968.2015.9.2.032-053","article-title":"Catastrophic antiphospholipid syndrome. Pathogenesis issues","volume":"2","author":"Bitsadze","year":"2015","journal-title":"Obstet. Gynecol. Reprod."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1515\/jpm-2017-0092","article-title":"Catastrophic antiphospholipid syndrome (Ronald Asherson syndrome) and obstetric pathology","volume":"46","author":"Makatsariya","year":"2018","journal-title":"J. Perinat. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/ard.2006.061671","article-title":"Catastrophic antiphospholipid syndrome during pregnancy and puerperium: Maternal and fetal characteristics of 15 cases","volume":"66","author":"Cervera","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0002-9343(99)80016-3","article-title":"Extensive bone marrow necrosis associated with antiphospholipid antibodies","volume":"98","author":"Bulvik","year":"1995","journal-title":"Am. J. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF00367379","article-title":"Widespread marrow necrosis during pregnancy","volume":"9","author":"Knickerbocker","year":"1982","journal-title":"Skelet. Radiol."},{"key":"ref_57","first-page":"195","article-title":"Bone marrow necrosis and refractory HELLP syndrome in a patient with catastrophic antiphospholipid antibody syndrome","volume":"29","author":"Sinha","year":"2002","journal-title":"J. Rheumatol."},{"key":"ref_58","first-page":"1017","article-title":"Early recognition of catastrophic antiphospholipid syndrome in patients with antiphospholipid syndrome based on a Chinese cohort study","volume":"41","author":"Huang","year":"2023","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1741-7015-11-185","article-title":"The Hyperferritinemic Syndrome: Macrophage activation syndrome, Still\u2019s disease, septic shock and catastrophic antiphospholipid syndrome","volume":"11","author":"Shoenfeld","year":"2013","journal-title":"BMC Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1038\/s41598-020-59990-5","article-title":"Antiphospholipid Antibody Testing in a General Population Sample from the USA: An Administrative Database Study","volume":"10","author":"Egiziano","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s11926-007-0034-x","article-title":"Antiphospholipid antibodies in response to infection","volume":"9","author":"Toplak","year":"2007","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/00003246-200204000-00007","article-title":"Frequent development of lupus anticoagulants in critically ill patients treated under intensive care conditions","volume":"30","author":"Wenzel","year":"2002","journal-title":"Crit. Care Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"ref_64","first-page":"923","article-title":"Catastrophic antiphospholipid syndrome and sepsis. A common link?","volume":"34","author":"Espinosa","year":"2007","journal-title":"J. Rheumatol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11420-008-9103-6","article-title":"Catastrophic Antiphospholipid Syndrome Triggered by Sepsis","volume":"5","author":"Kim","year":"2009","journal-title":"HSS J."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2050313X19839531","DOI":"10.1177\/2050313X19839531","article-title":"A probable case of catastrophic antiphospholipid syndrome: Should high-dose steroids be given in the setting of polymicrobial sepsis?","volume":"7","author":"Tucker","year":"2019","journal-title":"SAGE Open Med. Case Rep."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","article-title":"2001 SCCM\/ESICM\/ACCP\/ATS\/SIS International Sepsis Definitions Conference","volume":"31","author":"Levy","year":"2003","journal-title":"Crit. Care Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/ajh.20408","article-title":"Thrombocytopenic conditions-autoimmunity and hypercoagulability: Commonalities and differences in ITP, TTP, HIT, and APS","volume":"80","author":"Kravitz","year":"2005","journal-title":"Am. J. Hematol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.hoc.2007.11.001","article-title":"The relationship between the antiphospholipid syndrome and heparin-induced thrombocytopenia","volume":"22","author":"Hoppensteadt","year":"2008","journal-title":"Hematol. Clin. N. Am."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"6985020","DOI":"10.1155\/2020\/6985020","article-title":"A \u201cCatastrophic\u201d Heparin-Induced Thrombocytopenia","volume":"2020","author":"Barcellona","year":"2020","journal-title":"Case Rep. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s11420-007-9043-6","article-title":"Primary Antiphospholipid Syndrome Presenting as HELLP Syndrome","volume":"3","author":"George","year":"2007","journal-title":"HSS J."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41584-020-0474-5","article-title":"Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications","volume":"16","author":"Merrill","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.autrev.2006.06.008","article-title":"New subsets of the antiphospholipid syndrome in 2006: \u2018PRE-APS\u2019 (probable APS) and microangiopathic an-tiphospholipid syndromes (\u2018MAPS\u2019)","volume":"6","author":"Asherson","year":"2006","journal-title":"Autoimmun. Rev."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.autrev.2007.11.009","article-title":"Microvascular and microangiopathic antiphospholipid-associated syndromes (\u2018MAPS\u2019): Semantic or antisemantic?","volume":"7","author":"Asherson","year":"2008","journal-title":"Autoimmun. Rev."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"127","DOI":"10.15789\/2220-7619-CCA-1861","article-title":"Clinical characteristics and Laboratory tests in full-term Neonates with Sepsis in Vietnam National Children\u2019s Hospital","volume":"13","author":"Nguyen","year":"2023","journal-title":"Russ. J. Infect. Immun."},{"key":"ref_76","unstructured":"Fulton, M.R., Zubair, M., and Taghavi, S. (2023). Laboratory Evaluation of Sepsis, StatPearls Publishing."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/ACO.0000000000000958","article-title":"Epidemiology of sepsis and septic shock","volume":"34","author":"Chiu","year":"2021","journal-title":"Curr. Opin. Anaesthesiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00281-014-0416-x","article-title":"Hemolytic uremic syndrome","volume":"36","author":"Mele","year":"2014","journal-title":"Semin. Immunopathol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1055\/s-0037-1616068","article-title":"Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation","volume":"86","author":"Taylor","year":"2001","journal-title":"Thromb. Haemost."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1111\/jth.14192","article-title":"McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome","volume":"16","author":"Legault","year":"2018","journal-title":"J. Thromb. Haemost."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jaut.2018.07.001","article-title":"Catastrophic antiphospholipid syndrome: Lessons from 14 cases successfully treated in a single center. A narrative report","volume":"93","author":"Ruffatti","year":"2018","journal-title":"J. Autoimmun."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue","volume":"34","author":"Padmanabhan","year":"2019","journal-title":"J. Clin. Apher."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"100125","DOI":"10.1016\/j.rpth.2023.100125","article-title":"Catastrophic antiphospholipid syndrome in an immune thrombocytopenia patient treated with avatrombopag","volume":"7","author":"Vandenbriele","year":"2023","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1182\/hematology.2019000073","article-title":"Is there a role for immunosuppression in antiphospholipid syndrome?","volume":"2019","author":"Sevim","year":"2019","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Stanescu, C., Andronesi, A.G., Jurcut, C., Gherghiceanu, M., Vornicu, A., Burcea, F.A., Andronesi, T.D., Lupusoru, G.E., Iliuta, L., and Sorohan, B.M. (2021). Successful Treatment of Catastrophic Antiphospholipid Syndrome Using Rituximab: Case Report and Review of the Literature. Medicina, 57.","DOI":"10.3390\/medicina57090912"},{"key":"ref_86","first-page":"3226278","article-title":"Corticosteroids, Plasmapheresis, Argatroban, Rituximab, and Sirolimus Provided Clinical Benefit for Catastrophic Antiphospholipid Syndrome in a Patient with a History of Heparin-Induced Thrombocytopenia","volume":"2023","author":"Hasan","year":"2023","journal-title":"Case Rep. Rheumatol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1053\/j.ajkd.2019.08.032","article-title":"mTORC Pathway Activation and Effect of Sirolimus on Native Kidney Antiphospholipid Syndrome Nephropathy: A Case Report","volume":"76","author":"Dufour","year":"2020","journal-title":"Am. J. Kidney Dis."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e32949","DOI":"10.1097\/MD.0000000000032949","article-title":"Catastrophic antiphospholipid syndrome in lupus-associated immune thrombocytopenia treated with eltrombopag A case series and literature review","volume":"102","author":"Garra","year":"2023","journal-title":"Medicine"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e12584","DOI":"10.1097\/MD.0000000000012584","article-title":"Eculizumab in a pregnant patient with laboratory onset of catastrophic antiphospholipid syndrome: A case report","volume":"97","author":"Canti","year":"2018","journal-title":"Medicine"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/ard.2005.037671","article-title":"The acute respiratory distress syndrome in catastrophic antiphospholipid syndrome: Analysis of a series of 47 patients","volume":"65","author":"Bucciarelli","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"ref_91","first-page":"346","article-title":"The clinical spectrum of catastrophic antiphospholipid syndrome in the absence and presence of lupus","volume":"34","author":"Bayraktar","year":"2007","journal-title":"J. Rheumatol."},{"key":"ref_92","first-page":"2006","article-title":"Treatment of catastrophic antiphospholipid syndrome with defibrotide, a proposed vascular endothelial cell modulator","volume":"29","author":"Erkan","year":"2002","journal-title":"J. Rheumatol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archinte.1984.00350130043009","article-title":"Ancrod in systemic lupus erythematosus with thrombosis. Clinical and fibrinolysis effects","volume":"144","author":"Dosekun","year":"1984","journal-title":"Arch. Intern. Med."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/MBC.0000000000000848","article-title":"Dabigatran for catastrophic antiphospholipid syndrome","volume":"30","author":"Sarrate","year":"2019","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11926-009-0073-6","article-title":"Update on the Diagnosis, Treatment, and Prognosis of the Catastrophic Antiphospholipid Syndrome","volume":"12","author":"Cervera","year":"2010","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/rheumatology\/keac264","article-title":"Thrombocytopenia in primary antiphospholipid syndrome: Association with prognosis and clinical implications","volume":"62","author":"Shi","year":"2023","journal-title":"Rheumatology"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/annrheumdis-2013-204838","article-title":"Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: A multicentre prospective study of 1000 patients","volume":"74","author":"Cervera","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.jtha.2023.02.007","article-title":"Precipitating factors of catastrophic antiphospholipid syndrome: The role of anticoagulant treatment in a series of 112 patients","volume":"21","author":"Stammler","year":"2023","journal-title":"J. Thromb. Haemost."},{"key":"ref_99","first-page":"151","article-title":"The catastrophic antiphospholipid syndrome (Asherson\u2019s syndrome): Review of an uncommon and fatal complication of the antiphospholipid syndrome","volume":"5","author":"Asherson","year":"2004","journal-title":"Progress. Reumatol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41577-021-00536-9","article-title":"Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19","volume":"21","author":"Bonaventura","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1080\/17476348.2020.1801427","article-title":"Catastrophic antiphospholipid antibody syndrome and multiple organ dysfunctions in critically ill patients with COVID-19","volume":"14","year":"2020","journal-title":"Expert. Rev. Respir. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1007\/s10067-020-05310-1","article-title":"Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology","volume":"39","author":"Cardoso","year":"2020","journal-title":"Clin. Rheumatol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"17","DOI":"10.21292\/2078-5658-2021-18-1-17-26","article-title":"Catastrophic antiphospholipid COVID-19 syndrome","volume":"18","author":"Polushin","year":"2021","journal-title":"Vestn Anesteziol. Reanimatol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"232470962311657","DOI":"10.1177\/23247096231165736","article-title":"Catastrophic Antiphospholipid Syndrome as a Complication of COVID-19 Infection","volume":"11","author":"Bitterman","year":"2023","journal-title":"J. Investig. Med. High Impact Case Rep."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1056\/NEJMc2007575","article-title":"Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19","volume":"382","author":"Zhang","year":"2020","journal-title":"N. Engl. J. Med."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/1\/668\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:39:57Z","timestamp":1760103597000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/1\/668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,4]]},"references-count":105,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["ijms25010668"],"URL":"https:\/\/doi.org\/10.3390\/ijms25010668","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,4]]}}}